Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04126876 |
| Title | A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma (INTRIM) |
| Acronym | INTRIM |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | A.J.M. van den Eertwegh |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | NLD |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| VU Medical Centere | RECRUITING | Amsterdam | 1081 HV | Netherlands | Details |